Home » Topics » Conferences

Conferences
RSS

KY-455: Kyoto Pharm.'s ACAT/lipid peroxidation inhibitor

May 3, 1996

Vertex dedicates significant efforts to MDR-reversing agents

May 3, 1996

Eisai presents preliminary data on ER-34335

May 3, 1996

Selectin inhibitor GSC-150 effective in dermatitis models

May 3, 1996

MM-218 selected for development in emesis, diarrhea

April 26, 1996

OT-5226: New antidiabetic from Otsuka

April 26, 1996

Tanabe Seiyaku reports CCK-A antagonist for pancreatitis

April 26, 1996

Sanwa's SKK-47029 for disorders of gastric emptying

April 26, 1996

Terumo presents two new fibrinogen receptor antagonists

April 26, 1996

Japanese investigators reveal new agent for heart failure

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.